Contents
Key findings
- 1PT-141 (bremelanotide, brand Vyleesi) is the one sexual-health peptide with real, FDA-approved evidence.
- 2It works in the brain on desire and arousal - a different mechanism from Viagra, which works on blood flow.
- 3The approval is narrow - premenopausal women with low sexual desire - and the benefit is modest, with nausea very common (~40%).
- 4Its use in men, which is how it is mostly marketed online, was studied and then abandoned; there is no approval for men.
- 5Anything sold online as "PT-141" is not the FDA-approved product - it is unregulated and of unknown content.
Evidence level
For sexual health, PT-141 (bremelanotide) has by far the best evidence - it is FDA-approved for low sexual desire in premenopausal women based on two phase 3 trials. The benefit is real but modest, and comes with frequent nausea.
Regulatory status
PT-141 is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women only. It is not approved for men or anyone else, and products sold online as "PT-141" are not the approved drug.
Most "sexual health peptides" you will see advertised have no real evidence. There is one big exception - and it is genuinely FDA-approved. Here is the honest ranking, starting with the one that actually cleared the bar, and being clear about where the online marketing parts ways from the science.
The one that's actually approved: PT-141
PT-141 (bremelanotide), sold as Vyleesi, is the standout - and it is not close. It is FDA-approved for hypoactive sexual desire disorder (HSDD) - persistently low sexual desire that causes distress - in premenopausal women[1].
What makes it interesting is the mechanism. Unlike Viagra (which works on blood flow), PT-141 acts in the brain, on melanocortin pathways involved in desire and arousal. That is a genuinely different target - desire, not plumbing.
The evidence: two phase 3 trials (the RECONNECT program, ~1,267 women) found statistically significant improvements in desire and reduced distress versus placebo[1].
For the full breakdown, see PT-141: mechanism, approved use, benefits and limitations.
Grade: established, for its approved use (premenopausal women with HSDD).
The gap the marketing hides: PT-141 for men
Here is the honest part. Online, PT-141 is marketed heavily to men - but that is not the approved use. It was studied in men with erectile dysfunction back in the early 2000s, showed some effect, and then that development program was halted[1]. There is no FDA approval for men.
So the version of PT-141 most people are sold - injectable, for men, from a research-chemical site - is the least evidence-backed and least regulated version of an otherwise legitimate drug.
Everything else marketed for "sexual health"
Beyond PT-141, the peptides sold for libido and performance mostly rest on thin or no human evidence. Some are growth-hormone peptides borrowing a general "vitality" halo; others are simply marketing. None has anything like PT-141's approval or trial data for sexual health specifically.
The bottom line
For sexual health, one peptide has genuine evidence: PT-141, approved for a specific group of women, with a modest benefit and real side effects. The way it is sold online - injectable, to men, unregulated - is exactly the part with the least evidence behind it. Judge the specific version you are actually being offered.
Where to go next
- PT-141: mechanism, approved use, benefits and limitations
- Sexual health research hub
- FDA-approved, off-label, investigational and unapproved peptides
- Peptide safety hub
Frequently asked questions
- What is the best peptide for sexual health?
- PT-141 (bremelanotide) is the only one with FDA approval and real trial evidence. It is approved as Vyleesi for low sexual desire in premenopausal women. The benefit is genuine but modest, and nausea is common.
- Does PT-141 work for men?
- It is not approved for men. PT-141 was studied in men with erectile dysfunction in the early 2000s and showed some effect, but that development program was halted and it was never approved for men - even though that is how it is mostly marketed online.
- How is PT-141 different from Viagra?
- Viagra works on blood flow. PT-141 works in the brain, on the pathways behind desire and arousal. That is why it was developed for low desire rather than as a Viagra alternative.
- Is the PT-141 sold online the same as Vyleesi?
- No. Vyleesi is the FDA-approved, quality-controlled drug. 'PT-141' sold online as a research peptide is unregulated, and you cannot verify its purity, dose, or contents.
References
Numbered in order of first use. Study type is shown for every source; see our methodology for how we rank evidence.
- 1.
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials Obstetrics & Gynecology (Kingsberg et al.), 2019.
Randomized controlled trialPremenopausal women with acquired, generalised HSDDn = 1267
Result: Two randomized, double-blind, placebo-controlled 24-week phase 3 trials (RECONNECT): bremelanotide produced statistically significant but modest improvements in sexual desire and reduced distress versus placebo; nausea affected about 40% of women.
↑ back to text
Review status: Editorially reviewed against primary sources. This article was fact-checked against the primary sources listed in the references by our editorial team, and it has not been reviewed by a licensed clinician. It is educational content, not medical advice. Read our editorial policy and methodology. Spotted an error? Tell us.
